COVID-19 Update As Of May 12: 63,258 Specimens Examined, 4,608 New Cases Found

ILLUSTRATION/BETWEEN

JAKARTA - The Ministry of Health released additional positive cases of the latest COVID-19 as of today. A total of 63,258 specimens were examined there were 4,608 new positive cases of COVID-19

"The total accumulation of positive cases since COVID-19 was found in Indonesia reached 1,728,204 and active cases were 95,709 or down by 215 cases", as quoted from the Ministry of Health data, Wednesday, May 12.

Cases recovered today increased by 4,671 cases, bringing the total to 1,584,878 people cured. Then, the number of positive confirmation cases that died increased by 152 people and a total of 47,617 people.

The province with the newest cases was in West Java with 814 cases and a total of 294,779 cases. Followed by DKI Jakarta has 656 new cases and a total of 417,403 cases.

Then, Riau has 523 new cases and a total of 42,928 cases. Furthermore, West Sumatra has 443 new cases and a total of 40,017 cases, and East Java has 248 new cases and a total of 150,612 cases.

The province with the most cured cases today belongs to Riau with an increase of 779 cases. West Java with an increase of 753 cases recovered.

Next, DKI Jakarta with an increase of 674 cases recovered, South Kalimantan with an increase of 535 cases recovered, and Central Java with 292 cases cured.

In addition, the number of specimens examined using RT-PCR, TCM, and antigens reached 15,389,884. With details, RT PCR totals 13,708,149 specimens, TCM 175,426 specimens, and antigens 1,506,309 specimens.

"The positive result per number of specimens examined or positivity rate this week was 16.99 percent", it wrote.

For the number of people suspected of contracting COVID-19 or currently categorized as suspect cases, it is recorded at 87,043 people. Currently, 510 districts/cities from 34 provinces have had cases of COVID-19.

Currently, 13,678,323 people have received the first dose of COVID-19 vaccination and 8,909,265 second dose vaccinations. Meanwhile, the total vaccination target of phases 1 and 2 reached 40,349,049 people.